Diuretics and dopamine for the prevention and treatment of acute renal failure: A critical reappraisal

Journal of Nephrology

Volumn 15, Issue 3, 2002, Pages 213-219

  Gambaro, Giovanni ^a   Bertaglia, Giselda ^a   Puma, Giuseppe ^a   D'Angelo, Angela ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Acute renal failure; Atrial natriuretic peptide; Dopamine; Furosemide; Mannitol; Prevention; Torasemide

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CREATININE; DIURETIC AGENT; DOPAMINE; FUROSEMIDE; MANNITOL; PROSTAGLANDIN E2; TORASEMIDE;

ACUTE KIDNEY FAILURE; CLINICAL PRACTICE; CLINICAL TRIAL; CREATININE BLOOD LEVEL; CRITICAL ILLNESS; DIALYSIS; DISEASE EXACERBATION; DOPAMINE METABOLISM; DOSE RESPONSE; DRUG CLEARANCE; DRUG EFFICACY; GLOMERULUS FILTRATION RATE; HIGH RISK PATIENT; HUMAN; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; OBSTRUCTIVE JAUNDICE; OLIGURIA; REVIEW;

DIURETICS; DOPAMINE; HUMAN; KIDNEY FAILURE, ACUTE; HUMANS;

EID: 0035985299     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (74)

1. Lack of renoprotective effects of dopamine and furosemide during cardiac surgery
2. Dopamine and the kidney: Ten years on
3. Plasma dopamine concentration and effects of low dopamine doses on urinary output after major vascular surgery
4. Furosemide and dopamine in malarial acute renal failure
5. Low-dose dopamine in patients with early renal dysfunction: A placebo-controlled randomised trial
6. Use of dopamine in acute renal failure: A meta-analysis
7. Low dose dopamine hastens onset of gut ischemia in a porcine model of hemorrhagic shock
8. Dopamine and renal blood flow in radiocontrast-induced nephropathy in humans
9. Is the administration of dopamine associated with adverse or favourable outcomes in acute renal failure?
10. Renal-dose dopamine: Will the message now get through?
11. Low-dose dopamine in the intensive care unit: DNR or DNRx?
12. Effects of dopamine and aminophylline on contrast-induced acute renal failure after coronary angioplasty in patients with preexisting renal insufficiency
13. Dopamine clearance in critically ill patients
14. The renal response to low dose dopamine
15. Renal support in critically ill patients: Low-dose dopamine or dobutamine?
16. A comparison of dopexamine and dopamine to prevent renal impairment in patients undergoing orthotopic liver transplantation
17. Prolonged low-dose dopamine infusion induces a transient improvement in renal function in hemodynamically stable, critically ill patients: A single-blind, prospective, controlled study
18. Hypoxia of the renal medulla: Its implications for disease
19. Protective role of furosemide and saline in radiocontrast-induced acute renal failure in the rat
20. Furosemide in acute, oliguric renal failure: A controlled trial
21. High dose furosemide in acute renal failure: A controlled trial
22. Loop diuretics in the management of acute renal failure: A prospective, double-blind, placebo-controlled, randomised study
23. Mannitol, furosemide, and dopamine infusion in postoperative renal failure complicating cardiac surgery
24. Acute renal failure: A practical update
25. Restoration and maintenance of glomerular filtration by mannitol during hypoperfusion of the kidney
26. Diuretics in acute renal failure
27. Post-ischaemic administration of mannitol enhances erythrocyte trapping in outer medullary vasculature in the rat kidney
28. Mannitol-induced acute renal failure
29. Hemodynamic effects of continuous urodilatin infusion: A dose-finding study
30. Effects of atrial natriuretic peptide in clinical acute renal failure
31. Anaritide in acute tubular necrosis
32. Atrial natriuretic factor in oliguric acute renal failure
33. Urodilatin, a new peptide from the kidneys, can modify renal and cardiovascular function in men
34. Concomitant treatment with urodilatin (ularitide) does not improve renal function in patients with acute renal failure after major abdominal surgery - A randomised controlled trial
35. Therapeutic use of the natriuretic peptide ularitide in acute renal failure
36. Pathophysiologic features and prevention of human and experimental acute tubular necrosis
37. Mannitol as an indispensable constituent of an intraoperative hydration protocol for the prevention of acute renal failure after renal cadaveric transplantation
38. Flush solution with mannitol in the prevention of post-transplant renal failure
39. Effect of intravenous infusion of atriopeptin 3 on immediate renal allograft function
40. Atrial natriuretic factors does not improve the outcome of cadaveric renal transplantation
41. A randomised trial on the effect of mannitol on postoperative renal function in patients with obstructive jaundice
42. Prospective study of postoperative renal function in obstructive jaundice and the effect of perioperative dopamine
43. Perioperative renal protection in patients with obstructive jaundice using drug combination
44. Mannitol and renal function in cardiovascular surgery
45. Effects of post-operative low-dose dopamine on renal function after elective major vascular surgery
46. The beneficial effect of mannitol on postoperative renal function in children undergoing cardiopulmonary bypass surgery
47. Prevention of clinical acute tubular necrosis with drug therapy
48. The effect of furosemide on renal function in open heart surgery
49. Urodilatin, a new therapy to prevent kidney failure after heart transplantation
50. Significance of prophylactic urodilatin (INN: ularitide) infusion for prevention of acute renal failure in patients after heart transplantation
51. Potential deleterious effect of furosemide in radiocontrast nephropathy
52. Effects of saline, mannitol and furosemide on acute decreases in renal function induced by radiocontrast agents
53. Risk of radiocontrast nephropathy in patients with and without diabetes mellitus
54. The prevention of renal impairment in patients undergoing orthotopic liver grafting by infusion of low dose dopamine
55. Effect of intraoperative low-dose dopamine on renal function in liver transplant recipient
56. Prophylactic use of low-dose urodilatin for prevention of renal impairment following liver transplantation: A randomised placebo-controlled study
57. Reduced renal response to low-dose dopamine infusion in the elderly
58. Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure
59. Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure
60. The benefit of low-dose dopamine during vigorous diuresis for congestive heart failure associated with renal insufficiency: Does it protect renal function?
61. Effects of atrial natriuretic peptide on acute renal impairment in patients with heart failure after cardiac surgery
62. Urodilatin, a natriuretic peptide with clinical implications
63. Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine
64. Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide
65. New challenge of hepatorenal syndrome: Prevention and treatment
66. Interventions in clinical acute renal failure: What are the data?
67. Acute renal failure: Prevention and nondialytic therapy
68. Potential role of growth factors in the prophylaxis and treatment of acute renal failure
69. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine
70. Therapeutic strategies in the prevention of acute renal failure
71. Prevention of renal insufficiency after abdominal aortic aneurysm resection by optimal volume loading
72. Intraoperative management of renal function in the surgical patient at risk
73. Assessment of intravascular volume: A comedy of errors
74. Renal dose dopamine: Long on conjecture, short on fact